OCZ103-OS
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for OCZ103-OS, covering 2014-10-21 to 2014-10-21. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Study of OCZ103-OS in Combination With Standard of Care in Stage IV Non-Small Cell Lung Cancer (NSCLC) Patients [Phase 2]